Saturday, October 3, 2026
24.8 C
Bengaluru

The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research

The Data Graveyard: Why India’s Private Hospitals Fail at Medical Research

In India, the medical landscape presents a glaring paradox: private hospitals treat roughly 60% of the nation’s patients, yet the vast majority of institutions without attached colleges produce fewer than 10 research papers a year on average. Meanwhile, public medical colleges and premier academic centres carry almost the entire burden of the nation's medical research output. A recent study published in the Journal of Medical Evidence (BMJ Group) has exposed this systemic failure. Conducted by Dr Samiran Nundy and Dr Paramanand Tiwari from Delhi’s Sir Ganga Ram Hospital, the study analysed research output from January 2021 to December 2025 across Scopus, PubMed, and Google Scholar. Their findings reveal a troubling reality: while India ranks 4th globally in the sheer volume of medical publications, it drops to 9th in citation impact. The country treats millions, but it is failing to learn from them. Here is a deep dive into what India is missing, why it matters, and how to fix it.

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

Shakul Srivastava has been appointed as Senior Vice President at Indian Immunologicals Limited.

With over three decades of experience in the pharmaceutical...

The Rx–Outcomes Dichotomy: India Has Iron Tablets. Why Does Anaemia Persist?

India’s anaemia challenge is not simply about access to...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

Topics

Why Is the World’s Pharmacy Failing to Protect Patients from Harm?

This MedicinMan Intelligence Report follows a disturbing trail—from Arun...

10 Years of Pharma M&A — Who’s Really Benefited?

Pharmaceutical M&A is usually discussed in the language of...

What’s Killing Patients? Cancer or Rigged Drug Prices?

The disease is real. So is the markup. Confusing...

A Tale of Two Cities: Peptides and Prescriptions

What our health choices reveal about education, access and...

Trust Is Pharma’s Fulcrum: Are We Getting the Basics Right?

MedicinMan Intelligent Insights When Air India CEO Tewolde Gebremariam...
spot_img

Related Articles

spot_imgspot_img